生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BK4139 生物科技

未开盘 04-10 16:00:00 EDT

0.0000

+0.0000

--

最高0.0000	最低0.0000	成交量0.00
今开0.0000	昨收0.0000	日振幅0.00%
总市值0.00	流通市值0.00	总股本0.00
成交额0.00	换手率--	流通股本0.00
市净率--	ROE--	每股收益0.00
52周最高0.0000	52周最低0.0000	市盈率--
股息0.00	股息收益率0.00	ROA--

暂无数据

北京优虎网络科技有限公司

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"生物科技","latestPrice":795.1726,"timestamp":1744315199999,"preClose":824.4998,"halted":0,"volume":690424268,"delay":0,"changeRate":-0.03557,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-29.327209,"latestTime":"04-10 16:00:00 EDT","open":824.4985,"high":824.4985,"low":765.573,"amount":14841386920.849545,"amplitude":0.071468,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1744358400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.865672,"peRate":-39.229135,"increases":0,"decrements":0,"flats":0},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"2518181927","title":"再生元(REGN)与赛诺菲(SNY)抗炎药年中或迎新适应症获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2518181927","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518181927?lang=zh_cn&edition=full","pubTime":"2025-03-11 17:21","pubTimestamp":1741684881,"startTime":"0","endTime":"0","summary":"金吾财讯 | 再生元(REGN)与赛诺菲(SNY)在2025年美国皮肤科学会年会上公布，其IL-4/IL-13抑制剂Dupixent(达必妥)治疗中重度大疱性类天疱疮(BP)的2/3期ADEPT试验达到全部主要及关键次要终点：治疗组持续缓解率是安慰剂组的5倍。FDA已受理该适应症补充申请并授予优先审评，预计2025年年中获批。Dupixent作为全球首个获批的IL-4/IL-13双通路抑制剂，已在7大适应症(特应性皮炎、哮喘等)覆盖60多个国家，惠及超百万患者。此次新适应症针对自身免疫性大疱病，其独特的\"靶向抑制+免疫调节\"机制为传统疗法耐药患者提供新选择。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"286264","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","IE00BFXG1179.USD","LU0289739699.SGD","LU0058720904.USD","LU1974910355.USD","BK4139","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","LU1917777945.USD","BK4585","BK4007","BK4588","LU2468319806.SGD","LU2089984988.USD","LU0114720955.EUR","LU2106854487.HKD","SNY","LU2237438978.USD","LU2023250504.SGD","LU2362541513.USD","LU2362541273.HKD","LU2362540622.SGD","LU0053666078.USD","REGN","LU0882574055.USD"],"gpt_icon":0},{"id":"2518676594","title":"雷神科技：AURA智能眼镜（AI探索版）计划二季度正式上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2518676594","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518676594?lang=zh_cn&edition=full","pubTime":"2025-03-11 14:31","pubTimestamp":1741674699,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["AR","161631","LU1585245621.USD","BK4550","LU0683600562.USD","LU1430594728.SGD","BK4187","LU0320765646.SGD","LU1366192091.USD","LU1929549753.HKD","LU0787776722.HKD","BK4566","BK4585","IE00B3S45H60.SGD","LU1280957306.USD","AURA","BK4588","BK4213","LU1162221912.USD","LU0640476718.USD","BK4139","IE00B775SV38.USD"],"gpt_icon":0},{"id":"2518279020","title":"BMS收购CAR-T细胞疗法公司2seventy bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279020","media":"医药魔方","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518279020?lang=zh_cn&edition=full","pubTime":"2025-03-11 13:03","pubTimestamp":1741669423,"startTime":"0","endTime":"0","summary":"根据协议条款，BMS将立即开始一项要约收购，以每股5.00美元的价格以现金交易方式收购2seventy bio所有未发行的股份。在成功完成要约收购后，BMS将通过第二阶段合并以要约收购中的每股5.00美元的价格收购未在要约收购中提交的2seventy bio普通股的全部剩余股份。关于执行合并协议，持有2seventy bio约5.3%流通普通股的某些股东已根据协议签署要约和支持协议，以同意在要约中出让其持有的所有股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311131540abf5848e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311131540abf5848e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4022","BMS","TSVT","CAR","BK4230"],"gpt_icon":0},{"id":"2518730385","title":"深圳近450个“AI+医疗”产品落地，港股创新药ETF涨超1%，百济神州涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518730385","media":"21世纪经济报道","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518730385?lang=zh_cn&edition=full","pubTime":"2025-03-11 10:22","pubTimestamp":1741659768,"startTime":"0","endTime":"0","summary":"3月11日，港股早盘低开回升，恒生科技指数一度转涨，此前跌超2%，药品及生物科技板块盘中走强，相关ETF方面，港股创新药ETF涨超1%。消息面上，深圳近450个“AI+医疗”产品落地。据深圳市卫健委消息，深圳正推进人工智能技术在16类63个医疗卫生服务场景中落地应用。目前深圳粗略估计已经有近450个人工智能产品在全市医疗卫生机构落地应用。港股创新药ETF紧密跟踪港股通创新药指数，该指数反映港股通生物科技产业上市公司的运行特征。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110410598a343cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031110410598a343cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","ONC","688235","BK4139"],"gpt_icon":0},{"id":"2518735114","title":"百济神州因购股权获行使而发行约103.36万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2518735114","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518735114?lang=zh_cn&edition=full","pubTime":"2025-03-11 08:31","pubTimestamp":1741653060,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　百济神州（06160）发布公告，该公司因一名董事于2025年3月10日行使购股权而发行约103.36万股。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-11/doc-inepfvkv2864557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1583","BK1500","LU2328871848.SGD","LU1969619763.USD","ONC","BK1161","688235","BK1588","LU0307460666.USD","BK4139","06160","BK0239","LU0588546209.SGD"],"gpt_icon":0},{"id":"2518464787","title":"再生元(REGN.US)和赛诺菲(SNY.US)重磅抗炎药年中有望再添新适应症","url":"https://stock-news.laohu8.com/highlight/detail?id=2518464787","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518464787?lang=zh_cn&edition=full","pubTime":"2025-03-11 07:38","pubTimestamp":1741649927,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，日前，再生元和赛诺菲在2025年美国皮肤科学会年会上，公布了关键性2/3期临床试验ADEPT的积极结果。该试验评估重磅疗法Dupixent在治疗中重度大疱性类天疱疮成人患者时的疗效和安全性。ADEPT试验达到了所有主要及关键次要终点，接受Dupixent治疗的患者获得持久缓解的比例是安慰剂组的5倍。Dupixent治疗BP的补充生物制品许可申请已经获得FDA授予的优先审评资格，有望在今年年中获批。全球有超过100万名患者正在接受Dupixent治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260115.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0823416689.USD","IE00BFXG1179.USD","LU0289739699.SGD","LU0058720904.USD","LU1974910355.USD","BK4139","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","LU1917777945.USD","BK4585","BK4007","BK4588","LU2468319806.SGD","LU2089984988.USD","LU0114720955.EUR","LU2106854487.HKD","SNY","LU2237438978.USD","LU2023250504.SGD","LU2362541513.USD","LU2362541273.HKD","LU2362540622.SGD","LU0053666078.USD","REGN","LU0882574055.USD"],"gpt_icon":1},{"id":"2518785108","title":"Scinai Immunotherapeutics Ltd盘中异动 大幅下跌5.46%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518785108","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518785108?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:17","pubTimestamp":1741637834,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日04时17分，Scinai Immunotherapeutics Ltd股票出现波动，股价大幅下跌5.46%。截至发稿，该股报3.28美元/股，成交量6813股，换手率0.80%，振幅5.51%。Scinai Immunotherapeutics Ltd股票所在的生物技术行业中，整体涨幅为0.60%。Scinai Immunotherapeutics Ltd公司简介：Scinai Immunotherapeutics Ltd是一家生物制药公司，专注于开发、制造和商业化用于预防和治疗传染病和其他疾病的产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311041714abf39941&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311041714abf39941&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","SCNI","BK4139"],"gpt_icon":0},{"id":"2518178360","title":"Hookipa Pharma Inc.盘中异动 股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518178360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518178360?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:00","pubTimestamp":1741636828,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日04时00分，Hookipa Pharma Inc.股票出现异动，股价急速下挫5.28%。Hookipa Pharma Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Hookipa Pharma Inc.公司简介：HOOKIPA Pharma Inc是一家临床阶段生物制药公司，基于其专有的鼻病毒平台开发了针对传染性疾病和癌症的一类免疫疗法，该平台旨在重编程机体的免疫系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311040028abf3910a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311040028abf3910a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","HOOK"],"gpt_icon":0},{"id":"2518370200","title":"Sunshine Biopharma Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518370200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518370200?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:00","pubTimestamp":1741636818,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日04时00分，Sunshine Biopharma Inc.股票出现波动，股价大幅跳水5.02%。Sunshine Biopharma Inc.股票所在的制药行业中，整体跌幅为2.78%。其相关个股中，Sonoma Pharmaceuticals, Inc.、Medicus Pharma Ltd.、Sunshine Biopharma Inc C/Wts 涨幅较大，Sonoma Pharmaceuticals, Inc.、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为2075.15%、38.80%、31.78%，振幅较大的相关个股有Sonoma Pharmaceuticals, Inc.、Alvotech C/Wts 、Scilex Holding Company C/Wts 10/11/2027 ，振幅分别为60.30%、41.21%、35.91%。Sunshine Biopharma Inc.公司简介：Sunshine Biopharma Inc 是一家制药公司，在肿瘤学和抗病毒药物等多种治疗领域提供和研究救生药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031104001996407fec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031104001996407fec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBFM","BK4139"],"gpt_icon":0},{"id":"2518620705","title":"Entera Bio Ltd.盘中异动 临近收盘大幅下挫5.82%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518620705","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518620705?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:00","pubTimestamp":1741636815,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日04时00分，Entera Bio Ltd.股票出现异动，股价快速下跌5.82%。截至发稿，该股报1.78美元/股，成交量7.18万股，换手率0.19%，振幅8.77%。Entera Bio Ltd.股票所在的生物技术行业中，整体涨幅为0.72%。Entera Bio Ltd.公司简介：Entera Bio Ltd是一家临床阶段的生物制药公司，从事口服大分子疗法的开发，包括肽和治疗性蛋白质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311040015a26abb28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311040015a26abb28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENTX"],"gpt_icon":0},{"id":"2518783619","title":"Eledon Pharmaceuticals, Inc.盘中异动 临近收盘大幅跳水5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518783619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518783619?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:59","pubTimestamp":1741636796,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时59分，Eledon Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.41%。截至发稿，该股报3.59美元/股，成交量34.9116万股，换手率0.58%，振幅5.54%。Eledon Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Checkpoint Therapeutics, Inc.、Protagonist Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6578.13%、3906.94%、1043.46%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Eledon Pharmaceuticals, Inc.公司简介：Eledon Pharmaceuticals Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035957a26abaef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035957a26abaef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ELDN"],"gpt_icon":0},{"id":"2518839577","title":"Kezar Life Sciences, Inc.盘中异动 临近收盘急速下挫5.57%报5.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518839577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518839577?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:59","pubTimestamp":1741636760,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时59分，Kezar Life Sciences, Inc.股票出现波动，股价快速跳水5.57%。Kezar Life Sciences, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。其相关个股中，Checkpoint Therapeutics, Inc.、Protagonist Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6563.40%、3904.41%、1042.76%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Kezar Life Sciences, Inc.公司简介：Kezar Life Sciences Inc 是一家临床阶段生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103592098a2e63c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103592098a2e63c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KZR"],"gpt_icon":0},{"id":"2518077462","title":"Boundless Bio, Inc.盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518077462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518077462?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:57","pubTimestamp":1741636620,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时57分，Boundless Bio, Inc.股票出现波动，股价大幅下挫5.33%。截至发稿，该股报1.60美元/股，成交量21.9333万股，换手率0.98%，振幅6.51%。Boundless Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。其相关个股中，Checkpoint Therapeutics, Inc.、Protagonist Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6553.54%、3901.81%、1040.86%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Boundless Bio, Inc.公司简介：Boundless Bio Inc 是一家临床阶段肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035700a26ab9cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035700a26ab9cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BOLD","BK4139"],"gpt_icon":0},{"id":"2518786937","title":"Dermata Therapeutics, Inc.盘中异动 大幅拉升5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518786937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518786937?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:56","pubTimestamp":1741636602,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时56分，Dermata Therapeutics, Inc.股票出现波动，股价快速上涨5.65%。Dermata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Dermata Therapeutics, Inc.公司简介：Dermata Therapeutics Inc 是一家临床阶段的医学皮肤病学公司，专注于识别、开发和商业化用于治疗医学和美容皮肤状况的疾病候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035642abf38f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311035642abf38f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DRMA","DRMAW","BK4007","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2518200369","title":"Renovaro Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518200369","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518200369?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:50","pubTimestamp":1741636250,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时50分，Renovaro Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报0.859美元/股，成交量33.112万股，换手率0.20%，振幅6.95%。Renovaro Inc.股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，Checkpoint Therapeutics, Inc.、Protagonist Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6528.78%、3884.36%、1038.25%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Renovaro Inc.公司简介：Renovaro Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103505096407e6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103505096407e6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RENB","BK4139"],"gpt_icon":0},{"id":"2518785936","title":"Allovir, Inc.盘中异动 临近收盘大幅跳水5.98%报9.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518785936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518785936?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:47","pubTimestamp":1741636074,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时47分，Allovir, Inc.股票出现波动，股价快速跳水5.98%。截至发稿，该股报9.28美元/股，成交量2034股，换手率0.04%，振幅2.43%。Allovir, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。Allovir, Inc.公司简介：AlloVir Inc 是一家后期临床阶段的细胞治疗公司。该公司在一个细分市场内运营，致力于通过现成的 VST 疗法预防和治疗严重的病毒相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311034754abf38b3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311034754abf38b3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALVR","BK4139"],"gpt_icon":0},{"id":"2518242202","title":"Lava Therapeutics N.V.盘中异动 下午盘股价大跌5.56%报1.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518242202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518242202?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:36","pubTimestamp":1741635402,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时36分，Lava Therapeutics N.V.股票出现异动，股价大幅下跌5.56%。截至发稿，该股报1.36美元/股，成交量3.2311万股，换手率0.12%，振幅2.83%。Lava Therapeutics N.V.股票所在的生物技术行业中，整体涨幅为1.07%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6464.11%、3866.52%、1033.45%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Lava Therapeutics N.V.公司简介：LAVA Therapeutics NV是一家生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103364296407bdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031103364296407bdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LVTX","BK4539","BK4139"],"gpt_icon":0},{"id":"2518202735","title":"Quince Therapeutics, Inc.盘中异动 大幅跳水5.30%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518202735?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:18","pubTimestamp":1741634284,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时18分，Quince Therapeutics, Inc.股票出现波动，股价大幅下跌5.30%。Quince Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6316.63%、3862.24%、1024.29%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、72.15%。Quince Therapeutics, Inc.公司简介：Quince Therapeutics Inc 是一家临床前阶段的生物制药公司，专注于推进针对衰弱和罕见疾病的创新精准疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031804abf37cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031804abf37cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","QNCX","BK4139"],"gpt_icon":0},{"id":"2518209202","title":"Okyo Pharma Ltd Com Npv (Post Rev Split)盘中异动 急速跳水8.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518209202","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518209202?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:17","pubTimestamp":1741634260,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时17分，Okyo Pharma Ltd Com Npv 股票出现波动，股价急速下挫8.39%。Okyo Pharma Ltd Com Npv 股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为6315.61%、3862.21%、1024.25%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为90.44%、88.14%、63.07%。Okyo Pharma Ltd Com Npv 公司简介：OKYO Pharma Ltd 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031740964078a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311031740964078a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OKYO","BK4139"],"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0226},{"period":"1month","weight":-0.0564},{"period":"3month","weight":-0.0963},{"period":"6month","weight":-0.0949},{"period":"1year","weight":0.0203},{"period":"ytd","weight":-0.1049}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"name":"生物科技","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.3","shortVersion":"4.32.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"生物科技,BK4139,生物科技股票,生物科技股票老虎,生物科技股票老虎国际,生物科技行情,生物科技股票行情,生物科技股价,生物科技股市,生物科技股票价格,生物科技股票交易,生物科技股票购买,生物科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"生物科技(BK4139)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供生物科技(BK4139)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}